REQUEST A DEMO
Total
USD $0.00
Search more companies

E.S.E. Hospital Nuestra Senora de los Remedios (Colombia)

Main Activities: Hospitals
Full name: E.S.E. Hospital Nuestra Senora de los Remedios Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

E.S.E. Hospital Nuestra Senora de los Remedios is a company in Colombia, with a head office in San Jose de Miranda. The enterprise currently operates in the Hospitals sector. It was established on December 16, 2014. In its most recent financial highlights, the company reported a net sales revenue increase of 10.88% in Q3C2024. Its total assets grew by 74.43% over the same period. The net profit margin of E.S.E. Hospital Nuestra Senora de los Remedios increased by 45.66% in 2024.

Headquarters
Calle 5 # 5 08
San Jose de Miranda; Santander; Postal Code: 682021

Contact Details: Purchase the E.S.E. Hospital Nuestra Senora de los Remedios report to view the information.

Website: http://www.sanjosedemiranda-santander.gov.co

Basic Information
Outstanding Shares:
Purchase the E.S.E. Hospital Nuestra Senora de los Remedios report to view the information.
Incorporation Date:
December 16, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Head of Internal Control
Purchase this report to view the information.
Head of Budget
Company Performance
Financial values in the chart are available after E.S.E. Hospital Nuestra Senora de los Remedios report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
10.88%
Total operating revenue
44.76%
Operating profit (EBIT)
11517.31%
EBITDA
691.57%
Net Profit (Loss) for the Period
925.51%
Total assets
74.43%
Total equity
64.3%
Operating Profit Margin (ROS)
49.27%
Net Profit Margin
45.66%
Return on Equity (ROE)
18.31%
Quick Ratio
-298.67%
Cash Ratio
-129.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?